In AML cells, Bcr-TMP induces apoptotic and necrotic cell death, expression of myeloid differentiation markers, and down-regulation of direct MYB target genes, as exemplified by MYC, GFI1, and KIT. This evidence concerns the gene GFI1 and acute myeloid leukemia.